Table 2.
Outcomes of a clinical trial comparing family consultation to treatment as usual among patients with ESKD discharged from an urban hospital
| Variable | Family Consultation | Treatment as Usual | OR | 95% CI | P |
|---|---|---|---|---|---|
| Intent-to-treat analyses | (n=60) | (n=60) | |||
| 30-d readmissiona | 0.54 | 0.23 to 1.24 | 0.15 | ||
| Yes | 12 (20.0%) | 19 (31.7%) | |||
| No | 48 (80.0%) | 41 (68.3%) | |||
| 30-d any return visit | 0.53 | 0.25 to 1.11 | 0.09 | ||
| Yes | 19 (31.7%) | 28 (46.7%) | |||
| No | 41 (68.3%) | 32 (53.3%) | |||
| 6-mo readmission | 0.93 | 0.44 to 1.96 | 0.85 | ||
| Yes | 38 (63.3%) | 39 (65.0%) | |||
| No | 22 (36.7%) | 21 (35.0%) | |||
| 6-mo any return visit | 0.75 | 0.32 to 1.77 | 0.51 | ||
| Yes | 45 (75.0%) | 48 (80.0%) | |||
| No | 15 (25.0%) | 12 (20.0%) | |||
| Per-protocol analyses | (n=57) | (n=60) | |||
| 30-d readmission | 0.46 | 0.19 to 1.10 | 0.08 | ||
| Yes | 10 (17.5%) | 19 (31.7%) | |||
| No | 47 (82.5%) | 41 (68.3%) | |||
| 30-d any return visit | 0.45 | 0.21 to 0.96 | 0.04 | ||
| Yes | 16 (28.1%) | 28 (46.7%) | |||
| No | 41 (71.9%) | 32 (53.3%) | |||
| 6-mo readmission | 0.86 | 0.40 to 1.82 | 0.69 | ||
| Yes | 35 (61.4%) | 39 (65.0%) | |||
| No | 22 (38.6%) | 21 (35.0%) | |||
| 6-mo any return visit | 0.70 | 0.30 to 1.66 | 0.42 | ||
| Yes | 42 (73.7%) | 48 (80.0%) | |||
| No | 15 (25.0%) | 12 (20.0%) | |||
Data are presented as n (%). OR, odds ratio; 95% CI, 95% confidence interval.
a
Prespecified primary study outcome at the primary endpoint (30 d) in primary analyses (intent-to-treat). All other outcomes, endpoint, and analyses are secondary.